ArticleCellular and molecular bioengineering2021

Crystallization of the Multi-Receptor Tyrosine Kinase Inhibitor Sorafenib for Controlled Long-Term Drug Delivery Following a Single Injection.

Victoria Lai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.